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Alterations in glomerular dynamics in congenital, unilateral hydrone-
phrosis. We have previously shown that rats with congenital, unilateral
hydronephrosis exhibit a reduction in GFR that returns to normal when
either the renin angiotensin system or thromboxane A2 (TxA2) is
blocked. The current study defines the single nephron defect in con-
genital, unilateral hydronephrosis and evaluates the roles of angiotensin
II (Ang II) and TxA2 in this renal derangement. Renal micropuncture
experiments were performed on the right kidney of rats from an inbred
colony with unilateral right-sided hydronephrosis (HYDRO), or non-
affected litter mates (CONTROL). In addition, four separate groups of
hydronephrotic animals were treated with either the TxA2 receptor
antagonist SQ-29548 (SQ), one of two Ang II receptor antagonists[saralasin (SAR) or DuP-753 (DUP)], or combined treatment with
DuP-753 and SQ-29,548 (S&D). SNGFR was significantly reduced (P <
0.05) in HYDRO compared to CONTROL (17.6 2.0 vs. 35.9 3.7
ni/mm, respectively). Treatment with SQ-29,548 normalized SNGFR
(29.0 3.0 nl/min), while saralasin and DuP-753 resulted in only a
partial recovery of function (25.6 1.6 and 27.8 1.4 nllmin,
respectively). Combined SQ-29,548 and DuP-753 treatment resulted in
full recovery of SNGFR to 32.9 4.4 nllmin. The glomerular ultrafil-
tration coefficient (Kf) was reduced (P < 0.05) approximately 45% in
HYDRO compared to CONTROL (1.64 .08vs. 2.84 .22 nl/min/mm
Hg, respectively). K1 returned to control levels in SAR, DUP and SQ,
and increased above control in S&D (5.58 1.6nl/min/mm Hg). There
were no differences (P > 0.05) in hydrostatic or oncotic pressures
across the glomerular capillary between any of the groups studied. The
observation that K1 increases above CONTROL with combined block-
ade of TxA2 and Ang II suggests that these regulatory hormones
decrease K1 via independent mechanisms. These data indicate that the
reduction in SNGFR in congenital, unilateral hydronephrosis is a result
of a marked fall in K1 that is mediated by both Ang II and TxA2.
Hydronephrosis, the second leading cause of end-stage renal
disease in children [1], is frequently caused by a congenital,
complete or partial obstruction to urine flow. Timely surgical
alleviation of the obstruction will often restore some function to
the kidney [2, 3]. However, adequate recovery is not always
observed following successful repair, indicating that permanent
functional damage does occur in hydronephrosis [4—fl]. The
mechanism of the reduction in renal hemodyuamics in congen-
ital hydronephrosis, particularly those cases resulting from
partial ureteral obstruction, remains to be defined.
Our current understanding of obstructive uropathy is based
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primarily on observations made in animals with surgically-
induced uretet-al obstruction. Both bilateral (BUO) and unilat-
eral (UUO) complete ureteral obstruction have been studied
extensively [reviewed in 7]. It is clear from this body of
literature that complete ureteral obstruction for more than 24
hours results in a marked reduction in both GFR and SNGFR
[7—12]. The reduction in SNGFR in complete UUO is the result
of a pre-glomerular vasoconstnction which lowers glomerular
capillary hydrostatic pressure and hence the net filtration pres-
sure [10, 13]. This increase in renal vascular resistance has been
linked to the effects of both thromboxane A2 and angiotensin II
[11, 12, 14-16]. In addition, suppression of renal kallikrein gene
expression has recently been documented in the obstructed
kidney of UUO rats [16]. A reduction in bradykinin-mediated
renal vasodilation could contribute to the vasoconstricted state
of the UUO kidney. Current evidence indicates that the vaso-
constrictor forces in UUO supersede the effects of vasodilatory
paracrine agents such as PgE2 and Pg!2 [7] and EDRF [17]. The
predominant vasoconstrictor effect elicits a reduction in renal
blood flow and GFR in UUO.
While these studies provide a relatively clear understanding
of the pathogenesis of complete UUO, it is reasonable to
suspect, based on the dissimilar etiologies of complete UUO
and congenital hydronephrosis, that the pathogenesis of renal
dysfunction may be different. In congenital hydronephrosis, the
urogenital obstruction is usually partial and often develops
progressively in utero. To discern these potential differences
the short- and long-term effects of surgically-induced partial
UUO on renal morphology and hemodynamics have also been
fairly extensively studied [18—26]. While several reports of
substantial reduction in GFR and SNGFR in partial UUO have
been made [18, 20—22], other investigations have indicated that
GFR remains essentially unaffected by partial UUO [19, 23—26]
with little or no deterioration in function as the partial obstruc-
tion persists [23—25]. At the single nephron level, increases in
proximal tubule hydrostatic pressure [18, 20] and either ele-
vated [19] or normal [20] glomerular capillary hydrostatic
pressure (PGC) have been measured during partial UUO. A
reduction in the glomerular ultrafiltration coefficient (Kf) has
also been proposed to participate in the alteration in glomerular
hemodynamics [19, 20]. As with complete UUO, angiotensin II
[27, 28] and thromboxane A2 [29—31] have been implicated as
probable mediators of the alterations in glomerular function in
partial UUO.
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Congenital models of hydronephrosis have also been used to
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investigate potential mechanistic differences between surgically
induced complete UUO and hereditary hydronephrosis. Con-
genital hydronephrosis occurs only occasionally in normal rat
populations [24, 32—371; however, through selective breeding of
litter mates the incidence of hydronephrosis can be increased to
greater than 80% [24, 38]. In the few existing studies that have
been performed to examine renal function in congenital hydro-
nephrosis, GFR has been reported to be either normal [24, 33,
37] or markedly reduced [38—401. Studies in our laboratory have
focused on the renal derangements in rats with consistent
moderate to severe congenital, unilateral hydronephrosis of the
right kidney. Renal hemodynamics (GFR and RBF) are signif-
icantly reduced in these animals [38—401, and the renin-angio-
tensin system and thromboxane A2 have been implicated as
potential mediators of these renal derangements [39, 40]. These
observations have particular clinical importance since endoge-
nous formation of the renal paracrines PgE2 and TxA2 have
been reported to be selectively stimulated in hydronephrotic
kidneys in neonates and infants [41].
In order to extend our current understanding of the renal
functional abnormalities in congenital hydronephrosis, renal
micropuncture experiments were performed on congenitally
hydronephrotic rats to define the single nephron defect and to
determine the mechanism by which TxA2 and Ang II reduce
renal function in this model.
Methods
All of the experiments performed in these studies utilized
animals obtained from the hydronephrotic rat colony at Tulane
University School of Medicine. The colony, which has approx-
imately a 95% incidence of right-sided hydronephrosis in male
animals, has been described in detail previously [38]. Some of
the more prominent morphological features of these kidneys
with moderate to severe hydronephrosis include substantial
pelvicalyceal dilation, increased intrarenal diameter, decreased
medullary and papillary size with gross tissue loss, and occa-
sional tubular and epithelial flattening. Neither cysts nor cellu-
lar infiltration in interstitial and fornical areas have been ob-
served. Pelvicalyceal dilation has been detected at 8 to 10 days
of age and becomes more pronounced by 5 to 9 weeks. Recent
preliminary studies indicate that the hydronephrosis in this
model is due to partial obstruction at the ureteropelvic junction
[42].
During the course of these experiments the animals were
housed in laminar flow hoods on a 12 hour light/dark cycle,
were fed standard laboratory rat chow and provided drinking
water ad libitum.
Renal micropuncture protocol
On the day of the micropuncture experiment, a 12- to
15-week-old male rat, obtained from the colony, was anesthe-
tized with mactin (100 mg/kg, i.p.) and placed on a heated
surgical table to maintain proper body temperature (37 1°C).
A tracheostomy was performed to facilitate normal spontane-
ous breathing. The left carotid artery was cannulated (PE-50) to
allow continuous recording of arterial blood pressure and for
periodic sampling of blood. The right jugular vein was cathe-
terized for administration of a constant and continuous infusion
of 7.5% inulin (mutest; Laevosan-Gesellschaft, Austria) with
1% bovine serum albumin (BSA). Additional maintenance fluids
were not administered. Another catheter, placed in the left
jugular vein, was used for administration of pressor agents to
verify pharmacological blockade in appropriate groups and
supplemental anesthetic if needed. The right kidney was ex-
posed via a flank incision, cleared of perirenal fat and connec-
tive tissue, and placed in a LuciteT cup. Finally, an agar well
was built around the kidney and filled with 0.9% saline to
prevent desiccation of the kidney surface.
After a 30-minute surgical stabilization period and coinciden-
tal with at least 60 minutes of continuous inulin infusion, three
consecutive, 30 to 45 minute data collection periods were
begun. Each period was bracketed by arterial blood samples
(approximately 120 d) which were used for determination of
plasma inulin concentration (P1), hematocrit (Hct), and plasma
protein concentration (P). Mean arterial blood pressure
(MAP) and heart rate (HR) were recorded continuously during
the collection periods. Reported values of MAP, HR, Hct, and
are averages obtained during the three collection periods.
To determine SNGFR, four to six timed proximal fluid
samples were collected from random sites on the surface of the
kidney using micropipettes (10 to 12 tm tip diameter). Eleva-
tions in proximal tubular hydrostatic pressure were minimized
by carefully controlling the position of a mineral oil block within
the tubule. Efferent arteriolar blood samples were collected
from star vessels on the surface of the kidney into siliconized
(Sigmacote; Sigma Chemical Co., St. Louis, Missouri, USA)
and heparinized micropipettes (15 sm) and used for determina-
tion of efferent arteriolar protein concentration (CE). Afferent
arteriolar protein concentration (CA) was estimated from sys-
temic arterial blood collected into identically treated micropi-
pettes and processed in the same micro-assay as the efferent
blood collections. Oncotic pressure was calculated from the
micro-protein measurements using the Landis-Pappenheimer
equation [43, 44]. Finally, proximal tubule pressure (PT) and
stop flow pressure (SFP) were measured repetitively (that is, 4
to 6 measurements of each) using a servo-null pressure system
(Instrumentation for Physiology and Medicine, San Diego,
California, USA). The order in which these measurements were
made was randomized to minimize possible time-related changes.
Following completion of the third collection period, the
presence and degree of hydronephrosis was quantified by
measuring renal pelvic volume. The ureter of the micropunc-
tured kidney was completely ligated and two to four minutes
were allowed for the renal pelvis to fill with urine. The kidney
was then removed from the animal, blotted dry and weighed.
The kidney was then bisected longitudinally thereby draining
the accumulated urine, blotted dry again, and reweighed. The
degree of hydronephrosis was classified by comparing pelvic
volumes of experimental rats to pelvic volume measured in
preliminary experiments using seven normal (non-colony)
Wistar rats.
Experimental groups
Animals between 12 to 15 weeks of age were randomly
selected and treated with either saline-vehicle, saralasin, DuP-
753, SQ-29,548, or combined DuP-753 and SQ-29,548, as de-
scribed below. At the end of the experiment, pelvic volume was
measured as previously described to determine the presence
and severity of hydronephrosis. Vehicle-treated animals with a
normal pelvic volume were grouped as the normal control
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animals (CONTROL, N 6). Vehicle-treated animals with a
hydronephrotic right kidney (HYDRO, N = 8) were compared
to CONTROL to determine the glomerular defect in congenital
hydronephrosis.
Potential roles for angiotensin II (Ang II) and thromboxane
A2 (TxA2) in the reduced renal function in hydronephrosis were
investigated using pharmacological blockers of these systems in
separate groups of animals. The non-competitive Ang II recep-
tor antagonist saralasin (SAR[Sar',Va15,Ala8JAng II) was used
to evaluate the effects of Ang II on glomerular function in
hydronephrosis. In this group of animals (SAR, N 7),
saralasin was co-infused with the Inutest/BSA solution at a dose
of 20 g/kg/min. Effective blockade of Ang II receptors was
verified by recording the peak change in blood pressure follow-
ing bolus administration of Ang 11(100 ng i.v.) before beginning
the saralasin infusion and then at the end of the experimental
protocol. Because of the known partial agonist effects of
saralasin, a separate group of animals received the competitive,
non-peptide angiotensin AT-i receptor antagonist DuP-753
(DUP, N 7). DuP-753, known to effectively block the actions
of Ang II both in vitro and in vivo [45, 46], was administered to
this group of animals as a single intravenous bolus (10 mg/kg) at
the time the Inutest/BSA infusion was begun. Effective block-
ade with DuP-753 was verified using exogenous Ang II admin-
istration as described above. A potential role for TxA2 in the
reduced renal function in hydronephrosis was investigated by
administration of the thromboxane receptor antagonist SQ-
29,548 into a separate group of animals (SQ, N 7). SQ-29,548
is a potent and selective TxA2 receptor antagonist which has
been shown to block thromboxane-stimulated platelet aggrega-
tion and contraction of aortic and tracheal rings [47], as well as
inhibit TxA2 mediated increases in renal vascular resistance
[48]. The dose of SQ-29,548 used for these studies (10 g/kg/
mm, co-infused with the inulin solution) was selected based on
previous observations of a normalization of GFR following
administration of this antagonist to rats with congenital unilat-
eral hydronephrosis [40]. In the current study, effective block-
ade was verified by bolus administration of the TxA2 mimetic
U-46619 (100 ng i.v.) before and after administration of SQ-
29,548. Finally, to ascertain whether Ang II and TxA2 function
together as sequential steps in a common pathway or if they
work, at least in part, by independent mechanisms, a group of
animals received a combined treatment of SQ-29,548 and DuP-
753 (S&D, N = 5) at the same doses as before.
Analytical and statistical methods
Abbreviations and equations are listed in the Appendix.
Plasma inulin concentration was measured using the anthrone
method [49]. Inulin concentration in nanoliter volumes of
proximal tubular fluid was measured using the method of Vurek
and Pegram [501. P was measured using refractometry, while
CE and CA were measured using a Lowry assay modified for
micro-samples [51]. Oncotic pressure was calculated from CE
and CA using the Landis-Pappenheimer equation [43, 4411. All
reported values are mean SEM. All variables were analyzed
using a one-way ANOVA-randomized design. When appropri-
ate, Fisher's protected least significant difference (LSD) test
was performed to identify significant differences. Significance
was set at the level of P < 0.05.
Table 1. Systemic data for the six experimental groups
HR
PV
Group N ml
MAP
mmHg
beats!
mm
Hct
%
Ppr
g!dl
CONTROL 6 0.13 0.02 140 5 391 7 51 0.5 4.5 0.2
HYDRO 8 0.61 O.05 137 5 407 11 52 1 4.6 0.1
SQ 7 0.49 0.07a 129 2 420 10 51 1 4.5 0.1
SAR 7 0.60±0.lla 131±5 396± 12 49±2 4.6±0.1
DUP 7 0.65 o.loa 120 4 405 8 52 0.5 4.6 0.1
S&D 5 0.79 0.15 121 2 397 7 53 0.7 4.7 0.1
Abbreviations are: PV, renal pelvic volume; MAP, mean arterial
pressure; HR, heart rate; Hct, hematocrit; and pR, plasma protein
concentration. (N) represents the number of animal in each group.
Group designations are: colony animals with a normal right kidney
(CONTROL); and the following five groups are rats with congenital
hydronephrosis: animals that received vehicle (HYDRO); SQ-29,548
treated animals (SQ); saralasin treated rats (SAR); DuP-753 treated rats
(DUP); and animals treated with both SQ-29,548 and DuP-753 (S&D).
All values are mean SEM.
a p - 0.05 vs. CONTROL
Results
Pelvic volume measured in seven normal, non-colony, Wistar
rats averaged 0.12 0.02 ml. Colony animals with a pelvic
volume within 2 standard deviations of this normal value were
classified as having a normal right kidney and therefore served
as controls. Colony animals with a pelvic volume more than 4
standard deviations from normal were considered to have
moderate to severe hydronephrosis. If the pelvic volume of a
colony rat was between 2 and 4 standard deviations from
normal, the animal was considered indeterminate and was
eliminated from the study. Very few rats fell within this mild
hydronephrosis group (<5% of the animals studied). Rats with
congenital unilateral hydronephrosis (HYDRO) had a substan-
tial elevation in pelvic volume when compared to CONTROL
rats (Table 1). There were no appreciable differences (F> 0.05)
in HR or Hct among any of the groups (Table 1). MAP
measured in CONTROL and HYDRO in this study could be
considered slightly elevated compared to MAP routinely ob-
served in mactin-anesthetized rats prepared for renal mi-
cropuncture experiments. However, there was no difference in
MAP between HYDRO and CONTROL (140 5 and 137 5
mm Hg, respectively), suggesting that this increase in MAP is
not associated with the presence of hydronephrosis. MAP has
previously been reported to be slightly elevated [39] or within
the normal range [40] in anesthetized rats from this colony. In
the present study, MAP was significantly lower in rats treated
with DuP-753 (DUP) or combined DuP-753 and SQ-29,548
treatment (S&D) when compared to CONTROL.
Variables that determine the glomerular ultrafiltration profile for
each group are presented in Table 2 and Figures 1 and 2. There
were no substantial differences (P> 0.05) in P6, T, CA, C, A'
E' or ii among any of the six groups (Table 2). ranged
from 47 to 52 mm Hg. T was approximately 17 mm Hg in all
groups. CA ranged from 5.3 to 5.9 g/dl while CE ranged from 6.4 to
7.5 g/dl. A and rE were approximately 19 and 26 mm Hg,
respectively, in all groups. No differences were observed in
which ranged from 20 to 24 mm Hg.
Single nephron filtration rate in CONTROL averaged 35.9
3.8 nI/mm (Fig. lA) and was significantly lower in HYDRO
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Table 2. Renal micropuncture measurements made in the six groups of animals
Group N
'GC 1T CA C A E GC
Hg gld!mm mm Hg
CONTROL 6 48 1 16 1 5.3 0.3 6.4 0.4 17 1 23 2 20 I
HYDRO 8 50 2 18 1 5.6 0.4 6.8 0.4 19 2 25 2 21 2
SQ 7 52 1 17 1 5.9 0.2 7.4 0.2 20 1 28 1 24 I
SAR 7 47 2 17 1 5.4 0.2 6.9 0.2 18 1 25 1 21 1
DUP 7 50 2 17 1 5.9 0.2 6.8 0.2 20 1 25 1 22 1
S&D 5 47 2 18 1 5.6 0.2 7.0 0.2 18 1 26 1 22 1
Groups are defined in Table 1. Abbreviations are: P0, glomerular capillary hydrostatic pressure; T' proximal tubule hydrostatic pressure; CA
and C, systemic and efferent arteriolar protein concentration, respectively, measured by micro-Lowry assay; ITA and lT, systemic and efferent
arteriolar oncotic pressures, respectively; and average glomerular capillary oncotic pressure. All values are mean SEM.
(N) represents the number of animals in each group.
(17.6 2.0 nllmin). Blockade of the renin-angiotensin system
with either saralasin or DuP-753 resulted in a partial recovery of
function since SNGFR averaged 25.7 1.6 and 27.8 1.4
nl/min in SAR and DUP, respectively. SNGFR in these two
groups was different (P < 0.05) from both CONTROL and
HYDRO. SNGFR in SQ (29.0 3.0 nllmin) was significantly
greater than HYDRO and was not different (P > 0.05) from
CONTROL. Combined TxA2 and Ang II receptor blockade
(S&D) resulted in complete functional recovery; SNGFR aver-
aged 32.9 4.4 nl/min in this group, which was not different
from SNGFR in CONTROL.
Single nephron blood flow was also significantly reduced
(45%) in HYDRO compared to CONTROL (Fig. 1B), which
averaged 261 57 and 472 86 nl/min, respectively. In
contrast to the effects on SNGFR, treatment with either sarala-
sin or SQ-29,548 did not result in a significant increase in
SNBF. However, when the renin-angiotensin system was
blocked with DuP-753, SNBF, (473 52 nhlmin) was signifi-
cantly greater (P < 0.05) than SNBF observed in HYDRO and
indistinguishable from CONTROL. SNBF tended to increase
towards control levels in animals that received the combined
treatment of SQ-29,548 and DUP-753; however, SNBF in S&D
was not statistically different (P> 0.05) from either CONTROL
or HYDRO.
The glomerular capillary ultrafiltration coefficient K aver-
aged 2.84 0.22 nllmin/mm Hg in CONTROL (Fig. 2) and was
approximately 50% lower in HYDRO (1.64 0.08 nhlmin/mm
Hg). Blockade of either Ang II receptors or TxA2 receptors
resulted in an increase in K to levels indistinguishable from in
CONTROL. Combined SQ-29,548 and DuP-753 treatment in
hydronephrotic animals (S&D) resulted in an increase in Kf to
5.58 1.6 nhlminlmm Hg, a level significantly greater than
CONTROL.
Experimentally derived glomerular filtration pressure profiles
and NFP have been plotted for each group (Fig. 3). In this
figure, oncotic and hydrostatic pressures are plotted on the
y-axis. Distance along the glomerular capillaries is represented
on the x-axis with the boundaries being the afferent arteriole
(AA) and the efferent arteriole (EA). In each panel of Figure 3,
the filled circles represent i.\P which is calculated by subtracting
T from GC A one mm Hg drop in pressure, due to axial
pressure loss as the fluid moves through the glomerular capil-
lanes, has been assumed for iSP. The open circles represent
oncotic pressure in glomerular capillaries. Oncotic pressures,
A and grE, are values calculated from measured micro-protein
concentrations (CA and CE) using the Landis-Pappenheimer
equation. The area between the P line and the ii line repre-
sents NFP. The average NFP for each group is presented in the
squares between the two lines.
Net filtration pressure for CONTROL, HYDRO, and SQ
were not different from one another (13 1, 11 1, and 11
1 mm Hg, respectively, P > 0.05) and the filtration pressure
profiles for each of these groups were very similar. NFP for
SAR (8 1 mm Hg) and S&D (7 1 mm Hg), on the other
hand, were significantly lower (P < 0.05) compared to NFP in
CONTROL (13 1 mm Hg). This significant reduction in NFP
was quite evident in the filtration pressure profiles for these two
groups. Clearly, there was a striking difference in the filtration
profile in SAR and S&D compared to CONTROL, HYDRO, or
SQ. NFP tended to be reduced in the animals treated with
DuP-753 (10 1 mm Hg) compared to CONTROL; however,
this decrease did not quite reach statistical significance (P =
0.055).
Verification of effective Ang II and TxA2 receptor blockade is
summarized in Figure 4. Intravenous injection of 100 ng of Ang
II resulted in an approximate 33 mm Hg increase in MAP.
Blockade of Ang II receptors with either saralasin or DuP-753
reduced the increase in MAP to less than 2 mm Hg. Likewise,
100 ng of the TxA2 mimetic U-466l9 transiently increased MAP
by approximately 25 mm Hg prior to SQ-29,548 administration,
but only increased MAP by 4 mm Hg following TxA2 receptor
blockade.
Discussion
The current study extends previous observations of signifi-
cant reductions in whole kidney renal function in rats with
congenital, unilateral hydronephrosis [38—40] to the single
nephron level. SNGFR and SNBF were reduced approximately
50% in rats with a hydronephrotic kidney compared to non-
hydronephrotic litter mates. These decreases are consistent
with reductions in whole kidney function previously reported
following release of complete UUO [7—121, during partial UUO
[18, 20—221 and in congenital hydronephrosis [38—40]. It must be
noted that GFR and SNGFR have been reported to be within
the normal range during chronic partial UUO [19, 23—26] and in
some strains of rats with congenital hydronephrosis [24, 33, 37].
An explanation for such divergent results certainly must relate,
in part, to the varying degree of hydronephrosis observed in
surgically-induced and congenital models of hydronephrosis. In
addition, it is difficult to accurately assess GFR when measuring
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(N=7) (N=7) (N=7) (N=5)
rats, albeit probably not by as much as was previously reported
[38, 39].
Variability in the criteria utilized for identification of the
presence and degree of severity of hydronephrosis has lead to
some confusion in the literature as to the existence of renal
dysfunction in animal models of hydronephrosis. Conse-
quently, it is often difilcult to make direct comparisons between
studies from different laboratories. This issue would be best
addressed by accurate and standardized methods of documen-
tation of the severity of hydronephrosis in each kidney. In the
current study, pelvic volume was quantitatively measured. This
technique provided reliable and consistent estimates of pelvic
volume. Rats with a pelvic volume greater than 4 standard
deviations from normal were classified as hydronephrotic. This
criterion corresponds with moderate to severe hydronephrosis
determined by IVP and visual inspection used in previous
reports from our laboratory [38]. The results of the current
study—a substantial reduction in SNGFR (which is free of urine
dilutional artifacts) in moderate to severe hydronephrosis (doc-
umented by measurements of pelvic volume)—support previ-
ous observations of a reduction in GFR in congenital, unilateral
hydronephrosis.
Analysis of the individual determinants of SNGFR revealed
that Kf was the only variable significantly reduced in congeni-
tal, unilateral hydronephrosis in the rat. The hydrostatic and
oncotic pressures, P0w, PT' and WGC, were not different (P>
0.05) in HYDRO compared to CONTROL. It is important to
note that the animals in these experiments were in filtration
pressure disequilibrium (Fig. 3) thereby minimizing the effects
of changes in SNBF on SNGFR in this model. Although
determination of segmental resistances was not made in the
present study, the constant GC in CONTROL and HYDRO, in
light of a dramatic reduction in SNBF, suggests a similar
increase in both afferent and efferent arteriolar resistances. As
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Fig. 2. Glomerular ultrafiltration coefficient (K1) for all experimental
groups (defined in Table 1). * P < 0.05 vs. CONTROL.
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Fig. 1. Single nephron glomerular filtration rate (A; SNGFR) and
single nephron blood flow (B; SNBF) for all experimental groups
(defined in Table 1). All values are mean SEM. Animal numbers are
given in parentheses. *p < 0.05 vs. CONTROL; t P < 0.05 vs.
HYDRO.
urine concentration of clearance markers in animals with large
pelvic volumes [23].
We have recently addressed this latter issue in experiments
performed in rats obtained from our colony by using a constant
infusion technique to measure GFR. The constant infusion
technique obviates the necessity of urine collection. In that
report, GFR was significantly reduced approximately 25% in
hydronephrotic kidneys compared to control [40]. Those results
indicate that GFR is reduced in the affected kidney of these
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a consequence, GC is unchanged in the hydronephrotic kidney
and therefore does not contribute appreciably to the renal
dysfunction. Therefore, in congenital hydronephrosis the fall in
SNGFR is mediated primarily by a decrease in Kf.
In the current study SNGFR was measured by collecting
proximal tubule fluid and PGC was estimated from stop flow
pressure. Both of these procedures disrupt flow to the distal
nephron and as a result interrupt the normal tubuloglomerular
feedback ioop (TGF). Previous studies have shown that TGF
sensitivity is increased during volume expansion in partial UUO
[26, 30]; however, TGF has not been evaluated as of yet in rats
with congenital, unilateral hydronephrosis. Therefore, it is
currently unclear how disrupting TGF affects the conclusions of
the current study. It is possible that blocking flow to the distal
nephron could lead to afferent vasodilation and an elevation in
P. This possible TGF-mediated increase in GC couldmask a
participatory role for a reduction in glomerular capillary pres-
sure in congenital, unilateral hydronephrosis and artifactually
elevate SNGFR. The integrity of the TGF mechanism in rats
with moderate to severe congenital, unilateral hydronephrosis
remains to be evaluated and is beyond the scope of the current
report.
Our results, which highlight a reduction in Kf as the principal
renal defect in congenital hydronephrosis, are different from the
mechanisms of reduced GFR proposed for complete UUO
which have focused primarily on pre-glomerular vasoconstric-
tion and a resulting fall in P0 [7—13]. The results of the present
study are in agreement with micropuncture data obtained in
surgically-induced partial UUO which documented a reduction
in K [19, 20], and extend these observations for the first time to
a model of congenital, unilateral hydronephrosis. The reduction
in K in the present experiments was not offset by an increase in
PGC as was previously reported in mild partial UUO [19]. This
observation could suggest an important difference between
glomerular regulation between surgically-induced partial UUO
and the congenital setting. More likely, this apparent difference
reflects the difference in severity of hydronephrosis between
the animals in the current study and the previous report [19].
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Fig. 4. The pressor effect of 100 7g of Ang II or the TxA2 mimetic
U-46619 before (Pre) or after (Post) either saralasin, DuP-753, or
SQ-29,548. * P < 0.05 vs. Pre.
The rats in the current study appear to have a greater degree of
hydronephrosis.
At the single nephron level, SQ-29,548 treatment, which
effectively blocked TxA2 receptors, resulted in an increase in
K to control levels with a concomitant normalization of
SNGFR. SNBF, GC, T, and iiGC were unaffected by treat-
ment with SQ-29,548, indicating that thromboxane A2 alters
renal function in congenital unilateral hydronephrosis primarily
by decreasing Kf. Thromboxane receptors in the kidney have
been localized to glomeruli and mesangial cells [52—54] and
application of TxA2 to cultured mesangial cells results in cell
contraction [55]. Therefore, it seems reasonable to propose that
in congenital, unilateral hydronephrosis, TxA2 causes mesan-
gial cell contraction which, in turn, decreases K and results in
a decline in SNGFR.
Use of a selective TxA2 receptor antagonist (SQ-29,548) in
the present study has uncovered an important role for TxA2 in
glomerular regulation in partial UUO that may have been
missed in a previous study in which less specific cyclo-oxyge-
nase inhibitors, indomethacin and meclofenamate, were used
[19]. The conclusion made in that study that TxA2 plays a minor
role in glomerular regulation in partial UUO warrants reconsid-
eration.
The thromboxane-mediated decrease in outer cortical
SNGFR in congenital hydronephrosis is apparently indepen-
dent of a change in vascular tone as indicated by the lack of a
change in SNBF following TxA2 receptor antagonism. It was
somewhat unexpected to find that blockade of TxA2 did not
increase SNBF in outer cortical nephrons of congenitally hy-
dronephrotic kidneys since thromboxane effects on glomerular
function in complete UUO [11, 12, 14, 15] and in surgically-
induced partial UUO [29—31] have primarily been attributed to
alterations in renal vascular resistance. Whole kidney blood
flow responses to selective TxA2 blockade have not been
studied in congenital hydronephrosis, so it is presently unclear
whether TxA2 contributes to the reduction in RBF in this
model. Some investigators have suggested that the decline in
RBF elicited by thromboxane results from selective decreases
in medullary blood flow while cortical blood flow remains
unchanged [56]. In the present study, outer cortical SNBF was
unaltered following treatment with SQ-29,548, lending support
to the hypothesis that if thromboxane contributes to vasocon-
striction in congenital hydronephrosis then the effects may be
localized to the medullary circulation. This intriguing hypothe-
ses awaits further investigation.
The involvement of Ang II in the alteration of glomerular
function in congenital hydronephrosis was also investigated in
the current study. Ang II has been linked previously to the
reduction in renal hemodynamics observed in this model of
congenital, unilateral hydronephrosis [39, 40]. This observation
was extended in the present study which was designed to
investigate the single nephron mechanism of the recovery of
renal function observed with blockade of Ang II. Treatment
with saralasin increased Kf to control levels; however, only a
partial recovery of SNGFR was observed. SNBF, GC, T, and
ITGC were not altered by saralasin treatment. A second angio-
tensin receptor antagonist, DuP-753 (Losartan), also was used
in the current study to block the effects of Ang II. Like
saralasin, DuP-753 treatment normalized Kf but failed to return
SNGFR to control levels. The recovery of SNGFR in DuP-753
treated animals was only partial and similar in magnitude to
saralasin treated animals. A possible explanation is proposed
for the lack of full recovery of SNGFR in spite of a normaliza-
tion of K with two blockers of Ang II in a subsequent
discussion of the effects of saralasin and Dup-753 on NFP (Fig.
3).
In contrast to the effects of saralasin, DuP-753 resulted in an
increase in SNBF to levels indistinguishable from control,
suggesting that Ang II is responsible for the vasoconstriction
observed in outer cortical nephrons in congenital, unilateral
hydronephrosis. The difference observed in SNBF between
saralasin and DuP-753 treated animals is not easily explained
when one considers that both antagonists exerted similar effects
on Kf. However, binding of Ang II within glomeruli has been
reported to be more intense than binding of Ang II to afferent
and efferent arterioles [57], suggesting that differential glomer-
ular and vascular effects of Ang II could occur. Also, the
agonistic properties of saralasin [58] must be considered when-
ever this compound does not elicit expected vasodilation.
With these limitations of Ang II blockade in mind, and based
primarily on the observations made in DuP-753 treated animals,
Ang II appears to have two different effects on glomerular
regulation in congenital, unilateral hydronephrosis. First, Ang
II constricts both the afferent and efferent arterioles to a similar
degree resulting in a decrease in outer cortical SNBF, yet
remains unchanged. Since these animals are in a state of
filtration disequilibrium the reduction in SNBF does not con-
tribute significantly to the decreased SNGFR in the hydrone-
phrotic kidney. The second action of Ang II is to contribute to
a reduction in Kf.
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The combined treatment regimen of blocking both Ang II and
TxA2 receptors (S&D) resulted in an increase in K1 that was
larger in magnitude than either antagonist alone and also
precipitated a complete recovery of SNGFR. The significant
overshoot in Kf following combined treatment suggests that
TxA2 and Ang II are acting, at least in part, via separate
pathways.
One complicating issue in the current study is the observation
that in certain groups changes in Kf were not proportionately
matched by changes in SNGFR. Specifically, both saralasin and
DuP-753 completely reversed the fall in Kf, yet in these
hydronephrotic rats SNGFR failed to recover completely.
Likewise, combined Ang II and TxA2 antagonism (S&D) re-
sulted in a substantial overshoot in K1, but SNGFR only
returned to control levels. Since treatment with either antago-
nist alone or in combination resulted in no substantial changes
in any of the glomerular parameters other than Kf, an explana-
tion for the lack of proportional functional recovery is not
apparent. One possibility that warrants consideration is that
subtle alterations in each determinant of glomerular ultrafiltra-
tion, although insignificant individually, may have substantial
effects on the complete glomerular pressure proffie to decrease
net filtration pressure and thereby decrease SNGFR. To eval-
uate this possibility, the ultrafiltration profile and NFP were
determined for each group (Fig. 3).
Saralasin treatment resulted in a dramatic reduction in the
glomerular pressure profile and NFP compared to CONTROL
or HYDRO (Fig. 3). NFP in DuP-753 treated animals also
tended to decrease although the change was not statistically
different. It is possible that the fall in NFP would hinder
complete recovery of SNGFR in saralasin treated animals. If
one calculates SNGFR using the experimentally derived K1 for
SAR (3.36 nllmin/mm Hg) and normal NFP determined in these
experiments (CONTROL, -12 mm Hg), the calculated SNGFR
is approximately 17 nllmin higher than the measured SNGFR
(that is, approximately 40 ni/mm). This calculation, while highly
speculative, supports the hypothesis that the Ang II blockade
effects upon K1 are partially offset by a decrease in NFP.
A similar concern arises when one examines the effect of
combined Ang II and TxA2 receptor antagonism; the substantial
overshoot in Kf in the S&D group is not reflected in a similar
increase in SNGFR. The ultrafiltration profile analysis revealed
that in the S&D rats, K1 increased significantly above control
(5.58 1.63 nllminlmm Hg), SNGFR increased to control (32.9
4.4 nllmin), and NFP decreased significantly to 7 1 mm Hg.
Using the Kf determined in this group and normal NFP, the
calculated SNGFR is approximately 67 nllmin. This suggests
that if NFP were held constant in this group, SNGFR would
overshoot CONTROL as does Kf. Again, while highly specu-
lative, this analysis supports the concept that the primary
mechanism responsible for the decrease in SNGFR in this
model of congenital unilateral hydronephrosis is a reduction in
K1.
In summary, the reduction in GFR observed in congenital
unilateral hydronephrosis is associated with an approximate
50% reduction in SNGFR and SNBF. The decrease in SNGFR
is mediated primarily by a decrease in K1 since the hydrostatic
and oncotic pressures (PGc, PT, ITGC, and NFP) are not different
between HYDRO and CONTROL rats. Ang II receptor block-
ade increases K1 to control levels but only partially restores
SNGFR. The failure of SNGFR to recover completely is
possibly due to a significant fall in NFP in Ang II blocked
animals. Antagonism of TxA2 receptors normalizes both K1 and
SNGFR. Finally, combined blockade of Ang II and TxA2
receptors results in an increase in K1 to a level significantly
above control and a full recovery of single nephron function.
In conclusion, the substantial fall in whole kidney GFR,
previously reported in rats with congenital, unilateral hydrone-
phrosis, is the result of a similar reduction in SNGFR which is
mediated primarily by an Ang II- and TxA2-induced fall in Kf.
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Kf (ni/mm/mm Hg):
sure
Reprint requests to Richard C. Van, M.D., Department of Physiol-
ogy, P.O. Box 9001, University of North Dakota School of Medicine,
Grand Forks, North Dakota 58202, USA.
Appendix. Abbreviations/calculations
SNGFR (nl/min): Single nephron glomerular filtration
rate
SNFF:
SNPF (ni/mm):
SNBF (ni/mm):
TF (ni/mm):
CA and C (g/dl):
A and E (mm Hg):
oc (mm Hg):
Single nephron filtration fraction
Single nephron plasma flow
Single nephron blood flow
Proximal tubule flow
Protein concentrations of afferent
and efferent arteriolar plasma
(TF/P)1:
SFP (mm Hg):
PGC (mm Hg):
Net filtration pressure
Glomerular capillary ultrafiltration
coefficient
1TF\
SNGFR (ni/mm) = VTF —-)
/ CA\SNFF = —
SNGFR
SNPF (ni/mm) = SNFF
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SNPF
SNBF (ni/mm) i-Hct
GC = SFP + •ITA
= 2.1CA + 0.16CA2 + O.009CA3
ITE = 2.1CE + O.16CE2 + O.009CE3
—
ITA+ITE
ITGC 2
NFP = GC — — ITGC
= PGC -
SNGFR
Kf= NFP
References
1. U.S. Renal Data Systems, USRDS 1990 Annual Report, Bethesda,
NIH, National Institute of Diabetes and Digestive and Kidney
Disease, 1990, p 58
2. ALIABADI H, SIDI AA, GONZALEZ R: Management of ureteropelvic
junction obstruction in infants and neonates. Eur Urol 15:103—107,
1988
3. PETERS CA, CAlut MC, LAIs A, RanK AB, MANDELL J: The
response of the fetal kidney to obstruction, J Urol 148:503—509,
1992
4. BRATT CG, AVRELL M, JONSSON 0, NIL550N S: Long term follow
up of maximum concentrating ability and glomerular filtration rate
in adult obstructed kidney after pyeloplasy. J Urol 140:273—276,
1988
5. KING LR, HATCHER PA: Natural history of fetal and neonatal
hydronephrosis. Urology 35:433—437, 1990
6. CHURCHHILL BM, MCLORIE GA, KHOURY AE, MERGUERIAN PA,
HOULE AM: Emergency treatment and longterm follow-up of
posterior urethral valves. Urol Clin N Am 17:343—360, 1990
7. KLAFIR S: New insights into the consequences and mechanisms of
renal impairment in obstructive nephropathy. Am J Kidney Dis
18:689—699, 1991
8. HARRIs RH, YARGER WE: Renal function after release of unilateral
ureteral obstruction in the rat. Am J Physiol 227:806.-815, 1974
9. YARGER WE, GRIFFITH LD: Intrarenal hemodynamics following
chronic unilateral ureteral obstruction in the dog. Am J Physiol
227:816—826, 1974
10. DAL CANTON A, C0RRRDI A, STANZIALE R, MARUCCIO G, MIG-
ONE L: Effects of 24-hour unilateral ureteral obstruction on glomer-
ular hemodynamics in the rat. Kidney mt 15:457—462, 1979
11. YARGER WE, SCH0CKEN DD, HARRIS RH: Obstructive nephropa-
thy in the rat: Possible roles for the renin-angiotensin system,
prostaglandins, and thromboxanes in post obstruction renal func-
tion. J Gun Invest 65:400—412, 1980
12. PURKERSON ML, KLAHR S: Prior inhibition of vasoconstrictors
normalizes GFR in post obstructed kidneys. Kidney mt 35:1306—
1314, 1989
13. JAENIKE JR: The renal response to ureteral obstruction: A model
for the study of factors which influence glomerular filtration pres-
sure. J Lab Gun Med 76:373—382, 1970
14. KAWASAKI A, NEEDLEMAN P: Contribution of thromboxane to
renal resistance changes in the isolated perfused hydronephrotic
rabbit kidney. Circ Res 50:486—490, 1982
15. KLOTMAN PE, SMITH SR. VOLPP BD, COFFMAN TM, YARGER
WE: Thromboxane synthetase inhibition improves function of
hydronephrotic rat kidneys. Am J Physiol 250:F282—F287, 1986
16. EL-DAHR SS, GEE J, Dipp S, HANSS BG, VAR! RC, CHAO J:
Upregulation of renin-angiotensin system and downregulation of
kallikrein in obstructive nephropathy. Am J Physiol 264:F874—
F881, 1993
17. CHEVALIER RL, THORNHILL BA, GOMEZ RA: EDRF modulates
renal hemodynamics during unilateral ureteral obstruction in the
rat. Kidney mt 42:400—406, 1992
18. WILsoN DR: Micropuncture study of chronic obstructive nephrop-
athy before and after release on obstruction. Kidney mt 2:119—130,
1972
19. ICHIKAWA I, BRENNER BM: Local intrarenal vasoconstictor-vaso-
dilator interactions in mild partial ureteral obstruction. Am J
Physiol 236:Fl31—Fl40, 1979
20. CHEVALIER RL: Chronic partial ureteral obstruction in the neonatal
guinea pig H: Pressure gradients affection glomerular filtration rate.
PediatrRes 18:1271—1277, 1984
21. OLSON L: Renal function in experimental chronic hydronephrosis.
Scand J Urol Nephrol 10 (Suppl 32):5—l3, 1976
22. STaCKER JF, JR, GILLENWATER JY: Experimental partial ureteral
obstruction. Invest Urol 8:377, 1971
23. JOSEPHSON S, ERICSON A-E, SJOQUIST M: Experimental obstruc-
tive hydronephrosis in newborn rats VI: Long term effects on
glomerular filtration and distribution. J Urol 134:391—395, 1985
24. PROVOOST AP, VAN AKEN M, MOLENAR JC: Long term follow-up
of renal function in rats with unilateral hydronephrosis. Scan I Urol
Nephrol 24:127—132, 1990
25. PIEP5z A, HAM HR, HALL M, THOUA Y, FROIDEVILLE JL,
KINTHEART J, COLLIER F: Long-term follow-up of separate gb-
merular filtration rate in partially obstructed kidneys. Scan I Urol
Nephol 22:327, 1988
26. MORSING P, STENBERG A, MOLLER-SUUR C, PERSSON AEG:
Tubulogbomerular feedback in animals with unilateral, partial ure-
teral obstruction. Kidney hit 32:212—218, 1987
27. CHEVALIER RL, PEACH MJ: Hemodynamic effects of enalapril on
neonatal chronic partial ureteral obstruction. Kidney mt 28:891—
898, 1985
28. CHEVALIER RL, GOMEZ RA: Response of the renin-angiotensin
system to relief of neonatal ureteral obstruction. Am J Physiol
255:Fl070—F1077, 1989
29. CHEVALIER RL, JONES CE: Contribution of endogenous vasoactive
compounds to renal vascular resistance in neonatal chronic partial
ureteral obstruction. J Urol 136:532—535, 1986
30. MORSING P, STENBERO A, PERSSON AEG: Effect of thromboxane
inhibition on tubutoglomerular feedback in hydronephrotic kid-
neys. Kidney mt 36:447—452, 1989
31. KEKOMAKI M, VAPAATALO H: Renal excretion of prostanoids and
cyclic AMP in chronic partial ureteral obstruction of the rabbit. I
Urol 141:395—397, 1989
32. ASTARABADI T, BELL ET: Spontaneous hydronephrosis in albino
rats. Nature 195:392—393, 1962
33. HUMES HD, DIEPPA RA, BRENNER BM: Glomerular dynamics in
rats with hereditary hydronephrosis. Invest Urol 18:46—51, 1980
34. Lozzo BB, CHERNOFF A!, MACHADO EA, Lozzio CB: Heredi-
tary renal disease in a mutant strain of rats. Science 156:1742—1744,
1967
35. SELLERS AL, ROSENFELD S, FRIEDMAN NB: Spontaneous hydro-
nephrosis in the rat. Proc Soc Exp Biol Med 104:512—515, 1960
36. COHEN BJ, DEBRUIN RW, KORT WJ: Hereditable hydronephrosis
in a mutant strain of Brown Norway rats. Lab Animal Care 20:489,
1970
37. HENDERSON 1W, OLIVER JA, MILNE CM, BALMEUT RJ: Incidence
and some functional characteristics of hydronephrosis in Brattle-
boro rats. Ann NYAcad Sci 394:21, 1982
38. FRIEDMAN J, HOvER JR, MCCORMICK B, LEWY J: Congenital
unilateral hydronephrosis in the rat. Kidney mt 15:567—571, 1979
39. BOINEAU FG, VARI RC, LEWY JE: Reversible vasoconstriction in
rats with congenital unilateral hydronephrosis. Pediatr Nephrol
1:498—501, 1987
40. VARI RC, BOINEAU FG, LEWY JE: Angiotensin or thromboxane
receptor antagonism in rats with congenital hydronephrosis. I Am
Soc Nephrol 3:1522—1529, 1993
41. KOHL PG, SCHONIG G, SCHWEER H, SEYBERTH HW: Increased
renal biosynthesis of prostaglandin E2 and thromboxane 82 in
human congenital obstructive uropathy. Pediatr Res 27:103—107,
1990
